3 days 5 Large Drug Stocks to Keep An Eye On in the New Year Zacks
R&D innovation is likely to remain a major focus area in 2025. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), J&J (JNJ), AbbVie (ABBV), AstraZeneca (AZN) and Pfizer (PFE) are worth retaining in one’s portfolio.
Biotech · Health · Politics · U.S.
X